One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis. Data of the Spanish BIOBADASER registry
04/09/2024
Clementina López-Medina* 1 Lucía Otero-Varela 2 Fernando Sánchez-Alonso 2 Vega Jovani 3 Sagrario Bustabad Reyes 4 Sheila Melchor Díaz 5 Yanira Perez-Vera 6 Paula Pretel-Ruiz 7 Francisco Javier Manero Ruiz 8 Antonio Jose Mera-Varela 9 Lourdes Mateo 10 Dolores Ruiz-Montesino 11 María Colazo-Burlato 12 Maria Teresa Pedraz-Penalva 13 Isabel Castrejon 14
EULAR 2024
DOI: 10.1136/annrheumdis-2024-eular.3582
https://ard.bmj.com/content/83/Suppl_1/1494.1